The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study: Results From a Factorial, Randomized, Controlled Trial
Open accessAbstract
IMPORTANCE: Transcranial direct current stimulation (tDCS) trials for major depressive disorder (MDD) have shown positive but mixed results. OBJECTIVE: To assess the combined safety and efficacy of tDCS vs a common pharmacological treatment (sertraline hydrochloride, 50 mg/d). DESIGN: Double-blind, controlled trial. Participants were randomized using a 2 × 2 factorial design to sertraline/placebo and active/sham tDCS. SETTING: Outpatient, single-center academic setting in São Paulo, Brazil. PARTICIPANTS: One hundred twenty antidepressant-free patients with moderate to severe, nonpsychotic, unipolar MDD. INTERVENTIONS: Six-week treatment of 2-mA anodal left/cathodal right prefrontal tDCS (twelve 30-minute sessions: 10 consecutive sessions once daily from Monday to Friday plus 2 extra sessions every other week) and sertraline hydrochloride (50 mg/d). MAIN OUTCOME MEASURES In this intention-to-treat analysis, the primary outcome measure was the change in Montgomery-Asberg depression rating scale score at 6 weeks (end point). We considered a difference of at least 3 points to be clinically relevant. The analysis plan was previously published. Safety was measured with an adverse effects questionnaire, the young mania rating scale, and cognitive assessment. Secondary measures were rates of clinical response and remission and scores on other scales. RESULTS: At the main end point, there was a significant difference in Montgomery-Asberg depression rating scale scores when comparing the combined treatment group (sertraline/active tDCS) vs sertraline only (mean difference, 8.5 points; 95% CI, 2.96 to 14.03; P = .002), tDCS only (mean difference, 5.9 points; 95% CI, 0.36 to 11.43; P = .03), and placebo/sham tDCS (mean difference, 11.5 points; 95% CI, 6.03 to 17.10; P < .001). Analysis of tDCS only vs sertraline only presented comparable efficacies (mean difference, 2.6 points; 95% CI, -2.90 to 8.13; P = .35). Use of tDCS only (but not sertraline only) was superior to placebo/sham tDCS. Common adverse effects did not differ between interventions, except for skin redness on the scalp in active tDCS (P = .03). There were 7 episodes of treatment-emergent mania or hypomania, 5 occurring in the combined treatment group. CONCLUSIONS AND RELEVANCE: In MDD, the combination of tDCS and sertraline increases the efficacy of each treatment. The efficacy and safety of tDCS and sertraline did not differ. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01033084.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Physiological basis of transcranial direct current stimulation
Stagg, C. J., & Nitsche, M. A. (2011) · The Neuroscientist · doi:10.1177/1073858410386614 · Cited by 1,719
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Gandiga, P. C., Hummel, F. C., & Cohen, L. G. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.12.003 · Cited by 1,474
Brunoni, A. R., Nitsche, M. A., Bolognini, N., Bikson, M., Wagner, T., Merabet, L., Edwards, D. J., Valero-Cabre, A., Rotenberg, A., Pascual-Leone, A., et al. (2012) · Brain stimulation · doi:10.1016/j.brs.2011.03.002 · Cited by 1,445 · cited 1×
“technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.(10) Recent animal and human models have confirmed that tDCS induce…”
MethodSelf-citationLiebetanz, D. (2002) · Brain · doi:10.1093/brain/awf238 · Cited by 1,383
Brunoni, A. R., Amadera, J., Berbel, B., Volz, M. S., Rizzerio, B. G., & Fregni, F. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001690 · Cited by 1,234
Self-citationSafety aspects of transcranial direct current stimulation concerning healthy subjects and patients
Poreisz, C., Boros, K., Antal, A., & Paulus, W. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.01.004 · Cited by 1,099
Cited by
Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)
Lefaucheur, J.-P., Antal, A., Ayache, S. S., Benninger, D. H., Brunelin, J., Cogiamanian, F., Cotelli, M., De Ridder, D., Ferrucci, R., Langguth, B., et al. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.10.087 · Cited by 1,826
A technical guide to tDCS, and related non-invasive brain stimulation tools
Woods, A. J., Antal, A., Bikson, M., Boggio, P. S., Brunoni, A. R., Celnik, P., Cohen, L. G., Fregni, F., Herrmann, C. S., Kappenman, E. S., et al. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.11.012 · Cited by 1,439
Self-citationSafety of Transcranial Direct Current Stimulation: Evidence Based Update 2016
Bikson, M., Grossman, P., Thomas, C., Zannou, A. L., Jiang, J., Adnan, T., Mourdoukoutas, A. P., Kronberg, G., Truong, D., Boggio, P., et al. (2016) · Brain Stimulation · doi:10.1016/j.brs.2016.06.004 · Cited by 1,396
Self-citationAntal, A., Alekseichuk, I., Bikson, M., Brockmöller, J., Brunoni, A. R., Chen, R., Cohen, L. G., Dowthwaite, G., Ellrich, J., Flöel, A., et al. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.06.001 · Cited by 1,301
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Antidepressant effects of tDCS have been supported in recent larger studies (Brunoni et al., 2013; Loo et al., 2012) and a meta-analysis (Shiozawa et al.”
ResultFregni, F., El-Hagrassy, M. M., Pacheco-Barrios, K., Carvalho, S., Leite, J., Simis, M., Brunelin, J., Nakamura-Palacios, E. M., Marangolo, P., Venkatasubramanian, G., et al. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa051 · Cited by 605
Self-citationMilev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
“In the RCT examining tDCS and sertraline 50 mg/d, hypomania (3 patients, 10%) and mania (2 patients, 7%) were reported with the combined treatment compared to tDCS and sertraline alone (both with hypomania reported in 1 patient, 3%).(7) Adverse effects have not led to differences in dropout rates (*3%) between active…”
ResultParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Brunoni, A. R., Moffa, A. H., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, E., Alonzo, A., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.164715 · Cited by 414
Self-citationKuo, M.-F., Paulus, W., & Nitsche, M. A. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.117 · Cited by 415
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression
Brunoni, A. R., Moffa, A. H., Sampaio-Junior, B., Borrione, L., Moreno, M. L., Fernandes, R. A., Veronezi, B. P., Nogueira, B. S., Aparicio, L. V. M., Razza, L. B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612999 · Cited by 408
Self-citationHealth, T. L. G. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30432-0 · Cited by 417
“Although not a well-known treatment modality, rTMS is approved for clinical use in the United States, Israel, Canada, and Brazil.(15) tDCS.”
InfluentialJamil, A., Batsikadze, G., Kuo, H., Labruna, L., Hasan, A., Paulus, W., & Nitsche, M. A. (2017) · The Journal of Physiology · doi:10.1113/jp272738 · Cited by 397
Jakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366
Adverse events of tDCS and tACS: A review
Matsumoto, H., & Ugawa, Y. (2017) · Clinical Neurophysiology Practice · doi:10.1016/j.cnp.2016.12.003 · Cited by 349
Ekhtiari, H., Tavakoli, H., Addolorato, G., Baeken, C., Bonci, A., Campanella, S., Castelo-Branco, L., Challet-Bouju, G., Clark, V. P., Claus, E., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.007 · Cited by 297
Self-citationFregni, F., Nitsche, M. A., Loo, C. K., Brunoni, A. R., Marangolo, P., Leite, J., Carvalho, S., Bolognini, N., Caumo, W., Paik, N. J., et al. (2015) · Clinical Research and Regulatory Affairs · doi:10.3109/10601333.2015.980944 · Cited by 291
Self-citationChase, H. W., Boudewyn, M. A., Carter, C. S., & Phillips, M. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0499-9 · Cited by 286
Shiozawa, P., Fregni, F., Benseñor, I. M., Lotufo, P. A., Berlim, M. T., Daskalakis, J. Z., Cordeiro, Q., & Brunoni, A. R. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000418 · Cited by 282
“(Brunoni et al., 2013) and to the best of our knowledge, these results have not been included in tDCS metaanalyses yet.”
BackgroundMethodResultSelf-citationMartin, D. M., Liu, R., Alonzo, A., Green, M., & Loo, C. K. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-4022-x · Cited by 257
Meron, D., Hedger, N., Garner, M., & Baldwin, D. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.012 · Cited by 220
The neural crossroads of psychiatric illness: an emerging target for brain stimulation
Downar, J., Blumberger, D. M., & Daskalakis, Z. J. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.10.007 · Cited by 166
Transcranial direct current stimulation in psychiatric disorders
Tortella, G. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i1.88 · Cited by 154
Oliveira, J. F., Zanão, T. A., Valiengo, L., Lotufo, P. A., Benseñor, I. M., Fregni, F., & Brunoni, A. R. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.023 · Cited by 138
Self-citationChanging Brain Networks Through Non-invasive Neuromodulation
To, W. T., De Ridder, D., Hart Jr., J., & Vanneste, S. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00128 · Cited by 135
Salehinejad, M. A., Nejati, V., Mosayebi-Samani, M., Mohammadi, A., Wischnewski, M., Kuo, M.-F., Avenanti, A., Vicario, C. M., & Nitsche, M. A. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00501-x · Cited by 118
Ironside, M., O’Shea, J., Cowen, P. J., & Harmer, C. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.012 · Cited by 125
Soff, C., Sotnikova, A., Christiansen, H., Becker, K., & Siniatchkin, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1646-y · Cited by 111
Hone-Blanchet, A., Edden, R. A., & Fecteau, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.008 · Cited by 110
D'Urso, G., Brunoni, A. R., Mazzaferro, M. P., Anastasia, A., de Bartolomeis, A., & Mantovani, A. (2016) · Depression and Anxiety · doi:10.1002/da.22578 · Cited by 107
Self-citationMarin, M.-F., Camprodon, J. A., Dougherty, D. D., & Milad, M. R. (2014) · Depression and Anxiety · doi:10.1002/da.22252 · Cited by 106
Brunoni, A. R., Zanao, T. A., Vanderhasselt, M.-A., Valiengo, L., de Oliveira, J. F., Boggio, P. S., Lotufo, P. A., Benseñor, I. M., & Fregni, F. (2014) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12080 · Cited by 85
Self-citationCachoeira, C. T., Leffa, D. T., Mittelstadt, S. D., Mendes, L. S. T., Brunoni, A. R., Pinto, J. V., Blazius, V., Machado, V., Bau, C. H. D., Rohde, L. A., et al. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.009 · Cited by 79
Self-citationEffects of non-pharmacological pain treatments on brain states
Jensen, M. P., Sherlin, L. H., Askew, R. L., Fregni, F., Witkop, G., Gianas, A., Howe, J. D., & Hakimian, S. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.04.009 · Cited by 78
Self-citationCook (2014) · doi:10.1016/j.nec.2013.10.002 · Cited by 69
Senço, N. M., Huang, Y., D’Urso, G., Parra, L. C., Bikson, M., Mantovani, A., Shavitt, R. G., Hoexter, M. Q., Miguel, E. C., & Brunoni, A. R. (2015) · Expert Review of Medical Devices · doi:10.1586/17434440.2015.1037832 · Cited by 67
Self-citationBrunoni, A. R., Machado-Vieira, R., Zarate, C. A., Vieira, E. L. M., Vanderhasselt, M.-A., Nitsche, M. A., Valiengo, L., Benseñor, I. M., Lotufo, P. A., Gattaz, W. F., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.006 · Cited by 60
“…properties in the treatment of psychiatric disorders (Kuo et al., 2013), and, among those, tDCS has been particul rly investigated for major depressive disorder (MDD) (Brunoni et al., 2012a), with recent and large trials showing positive outcomes (Brunoni et al., 2013b; Loo et al., 2012).”
BackgroundResultInfluentialSelf-citationLeffa, D. T., de Souza, A., Scarabelot, V. L., Medeiros, L. F., de Oliveira, C., Grevet, E. H., Caumo, W., de Souza, D. O., Rohde, L. A. P., & Torres, I. L. S. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.012 · Cited by 50
“This would be the subject of an entirely worthwhile research project, since it has been shown that in depression there seems to be a synergic effect of tDCS and sertraline (Brunoni et al., 2013), which could also be the case in ADHD.”
BackgroundA Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Singh, A., Erwin-Grabner, T., Goya-Maldonado, R., & Antal, A. (2020) · Neuropsychobiology · doi:10.1159/000502149 · Cited by 23
Transcranial direct current stimulation: considerations for research in adolescent depression
Lee, J. C., Lewis, C. P., Daskalakis, Z. J., & Croarkin, P. E. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00091 · Cited by 22
“(1) 103 Yes (1) Anodal L-DLPFC (cathode RSO) 1 mA, 20 min/day, five sessions MADRS Combination treatment with sertraline 50 mg and tDCS outperformed sertraline alone (p = 0.”
BackgroundMethodInfluentialNeurochemical mechanisms underlying serotonergic modulation of neuroplasticity in humans
Melo, L., Beaupain, M. C., Ghanavati, E., Kuo, M.-F., & Nitsche, M. A. (2024) · Brain Stimulation · doi:10.1016/j.brs.2024.04.001 · Cited by 15
Can seizure therapies and noninvasive brain stimulations prevent suicidality? A systematic review
Chen, Y., Magnin, C., Brunelin, J., Leaune, E., Fang, Y., & Poulet, E. (2021) · Brain and Behavior · doi:10.1002/brb3.2144 · Cited by 13
Social Psychology and Noninvasive Electrical Stimulation: A Promising Marriage
Boggio, P. S., Rêgo, G. G., Marques, L. M., & Costa, T. L. (2016) · European Psychologist · doi:10.1027/1016-9040/a000247 · Cited by 13
Self-citation
Metadata
- Authors
- Brunoni, A. R., Valiengo, L., Baccaro, A., Zanão, T. A., de Oliveira, J. F., Goulart, A., Boggio, P. S., Lotufo, P. A., Benseñor, I. M., & Fregni, F.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2013-04-01
- Volume
- 70
- Issue
- 4
- Pages
- 383
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2169624269
- Cited by
- 601
- References
- 61
- FWCI
- 30.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.